On October 15, Kechuang 100 (588190) closed down 2.58%, with a turnover of 662 million yuan.
STAR 100 ETF (588190) was established on September 6, 2023, and the full name of the fund is Yinhua SSE Science and Technology Innovation Board 100 ETF ETF, and the fund is referred to as STAR 100. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the STAR 100 ETF (588190) is based on the return rate of the SSE STAR Market 100 Index.
In terms of scale, as of October 14, the latest share of the Science and Technology Innovation 100 ETF (588190) was 7.712 billion shares, and the latest scale was 6.595 billion yuan. Looking back on December 29, 2023, the share of the STAR 100 ETF (588190) was 3.035 billion shares, with a scale of 2.960 billion yuan. That is, the share of the fund has increased by 154.12% and the scale has increased by 122.78% since the beginning of this year.
In terms of liquidity, as of October 15, the cumulative turnover of Kechuang 100 ETF (588190) in the past 20 trading days was 15.121 billion yuan, with an average daily turnover of 756 million yuan, and since the beginning of this year, the cumulative turnover in 187 trading days has been 43.505 billion yuan, with an average daily turnover of 233 million yuan.
The current fund managers of Kechuang 100 ETF (588190) are Zhang Yichi and Ma Jun. Zhang Yichi has managed (or intends to manage) the fund since September 6, 2023, with a return of -14.48% during his tenure; Ma Jun has managed (or intends to manage) the fund since September 6, 2023, with a return of -14.48% during his tenure.
According to the latest regular report, the heavy stocks of the Science and Technology Innovation 100 ETF (588190) include Huitai Medical, Nine Company, Allist, BeiGene, Smartway, Anji Technology, Hengxuan Technology, Borui Pharmaceutical, NOVOSENSE, and Zhuhai Guanyu, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 688617 | Huitai Medical | 3.75%, | 150,568,661,800 | |
| 689009 | No. 9 Company | 3.24%, | 1,611,959,332,200 | |
| 688578 | Allist | : 2.52%, | 725,600, 725,250,700 | |
| 688235 | BeiGene | , 2.34%, | 369,42791,900 | |
| 688213 | Smartway | 2.04%, | 769,337,309,400||
| 688019 | Anji Technology | 2.01%, | 292,536,795,900 | |
| 688608 | Hengxuan Technology | 1.85%, | 231,900, | 233,946,700 |
| 688166 | Borui Pharmaceutical | , 1.82%, | 954,433,403,500 | |
| 688052 | NOVOSENSE | 1.80%, | 321,6033,052,700||
| 688772 | Zhuhai Guanyu | 1.77%, | 2,176,532,429,500 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
